HM
Hua Medicine
China - Shanghai
BiotechnologyFocus: Small Molecules
Hua Medicine is a life sciences company focused on Small Molecules.
Metabolic DiseasesRespiratoryNeurologyInfectious DiseasesOncology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
China Headache and Vertigo Registry Study
Headache Disorders, PrimaryClinical Trials (1)
NCT04939922China Headache and Vertigo Registry Study
N/AInternational Headache Registry Study
Headache Disorders, PrimaryClinical Trials (1)
NCT05418218International Headache Registry Study
N/AN/A
Clinical Trials (1)
NCT04128280Multi-center Clinical Observation of a New Treatment Method Based on the Pathogenesis of Obstructive Prostatitis
N/Atraditional chinese medicine Xuanfei-Zhike formula
Cough Variant AsthmaClinical Trials (1)
NCT05459805Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine
N/ASuper High-Pressure Non-Compliant Balloon
Vascular CalcificationClinical Trials (1)
NCT07279987Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions
N/ATotal Laparoscopic or Robotic Radical Hysterectomy
Cervical CancerClinical Trials (1)
NCT04934982Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
N/APost-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Adverse Drug ReactionClinical Trials (1)
NCT01946919Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
N/ATianqi Pingchan Granule
Levodopa-Induced DyskinesiaClinical Trials (1)
NCT04173845Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
N/ACGRP R Inhibitor; CGRP Inhibitor
Vestibular MigraineClinical Trials (1)
NCT07203248Chinese Real-world Study of Treatment of Vestibular Migraine
N/ANeurologic Manifestations of COVID-19
Coronavirus Disease 2019Clinical Trials (1)
NCT04386083Neurologic Manifestations of COVID-19
N/Aurgent-start peritoneal dialysis catheter
End-Stage Renal DiseaseClinical Trials (1)
NCT02946528Urgent-start Peritoneal Dialysis in ESRD Patients:A Multi-center Study
N/ADorzagliatin
Drug InteractionClinical Trials (1)
NCT04080596DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin
Phase 1HMS5552
Type 2 Diabetes MellitusClinical Trials (1)
NCT02077452Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
Phase 1HMS5552
Healthy SubjectClinical Trials (1)
NCT03158506Human Mass Balance Study of HMS5552 in Healthy Subjects
Phase 1HMS5552
Type II Diabetes MellitusClinical Trials (1)
NCT01952535A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral HMS5552 in Healthy Volunteers
Phase 1Sitagliptin
PatientsClinical Trials (1)
NCT03790839Drug Interaction Study Between Dorzagliatin and Sitagliptin
Phase 1HMS5552
Type 2 Diabetes MellitusClinical Trials (1)
NCT04426708A Clinical Study to Access the Pharmacokinetics of HMS5552 in Hepatic Impaired Subjects and Healthy Volunteers
Phase 1Dorzagliatin
Drug InteractionClinical Trials (1)
NCT04080609DDI Study Between Dorzagliatin and Rifampicin
Phase 1Empagliflozin
PatientsClinical Trials (1)
NCT03790787Drug Interaction Study Between Dorzagliatin and Empagliflozin
Phase 1HMS5552
Type 2 Diabetes MellitusClinical Trials (1)
NCT04324424A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers
Phase 1Metformin
Type 2 Diabetes MellitusClinical Trials (1)
NCT02597400Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
Phase 1HMS5552
Type 2 DiabetesClinical Trials (1)
NCT02386982Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients
Phase 1HM-002-1005
Diabetes Mellitus, Type IIClinical Trials (1)
NCT06498284Evaluate HM-002-1005 in Subjects With Type 2 Diabetes Mellitus
Phase 1HMS5552
Diabetes Mellitus, Type 2Clinical Trials (1)
NCT02561338A Multi-center 12-week Study of HMS5552 in T2DM
Phase 2HMS5552
Diabetes Mellitus, Type 2Clinical Trials (1)
NCT03141073Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects
Phase 3HMS5552
Diabetes Mellitus, Type 2Clinical Trials (1)
NCT03173391Long-term Efficacy and Safety of HMS5552 in T2DM Subjects
Phase 3Recombinant Human Growth Hormone Injection
DwarfismClinical Trials (1)
NCT03535415A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
Phase 3Dorzagliatin tablets
Type2diabetesClinical Trials (1)
NCT06263348A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Phase 4Telbivudine
Hepatitis B InfectionClinical Trials (1)
NCT01788371Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 29 clinical trials
Top TAs: Metabolic Diseases, Neurology, Infectious Diseases
Publications: 25 in PubMed
Therapeutic Area Focus
Metabolic Diseases
11 pipeline
Neurology
4 pipeline
Infectious Diseases
1 pipeline
Nephrology
1 pipeline
Oncology
1 pipeline
Respiratory
1 pipeline
Marketed
Pipeline